SCIENTURE HOLDINGS, INC. Notes Payable
SCIENTURE HOLDINGS, INC. (SCNX) had Notes Payable of $6.55 million as of 2023-12-31, per its 10-K filed 2024-04-22.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:NotesPayable · last filed 2024-04-22
- 2023-12-31: Notes Payable $6.55M.
- 2023-09-30: Notes Payable $5.25M.
- 2022-09-30: Notes Payable $333.33K.
- 2022-06-30: Notes Payable $333.33K.
| Period end | Notes Payable |
|---|---|
| 2023-12-31 | $6.55M 10-K · filed 2024-04-22 |
| 2023-09-30 | $5.25M 10-Q · filed 2024-01-16 |
| 2022-09-30 | $333.33K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $333.33K 10-Q · filed 2022-07-25 |
| 2015-12-31 | $235.00K 10-K · filed 2016-03-28 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |